Biochemical aspects of articular disease.
Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Pennod
StandardStandard
Biochemical aspects of articular disease. / Jones, Jeremy; Marshall, W.J. (Golygydd); Bangert, S.K. (Golygydd).
Clinical Biochemistry: Metabolic and Clinical Aspects. 2008. gol. Churchill Livingstone, 2008. t. 660-668.
Clinical Biochemistry: Metabolic and Clinical Aspects. 2008. gol. Churchill Livingstone, 2008. t. 660-668.
Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Pennod
HarvardHarvard
Jones, J, Marshall, WJ (gol.) & Bangert, SK (gol.) 2008, Biochemical aspects of articular disease. yn Clinical Biochemistry: Metabolic and Clinical Aspects. 2008 gol., Churchill Livingstone, tt. 660-668.
APA
Jones, J., Marshall, W. J. (Gol.), & Bangert, S. K. (Gol.) (2008). Biochemical aspects of articular disease. Yn Clinical Biochemistry: Metabolic and Clinical Aspects (2008 gol., tt. 660-668). Churchill Livingstone.
CBE
Jones J, Marshall WJ, Bangert SK, gol. 2008. Biochemical aspects of articular disease. Yn Clinical Biochemistry: Metabolic and Clinical Aspects. 2008 gol. Churchill Livingstone. tt. 660-668.
MLA
Jones, Jeremy, W.J. Marshall a S.K. Bangert, gol. "Biochemical aspects of articular disease.". Clinical Biochemistry: Metabolic and Clinical Aspects. 2008 udg., Churchill Livingstone. 2008, 660-668.
VancouverVancouver
Jones J, Marshall WJ, (ed.), Bangert SK, (ed.). Biochemical aspects of articular disease. Yn Clinical Biochemistry: Metabolic and Clinical Aspects. 2008 gol. Churchill Livingstone. 2008. t. 660-668
Author
RIS
TY - CHAP
T1 - Biochemical aspects of articular disease.
AU - Jones, Jeremy
A2 - Marshall, W.J.
A2 - Bangert, S.K.
PY - 2008/1/1
Y1 - 2008/1/1
M3 - Chapter
SN - 0443101868
SP - 660
EP - 668
BT - Clinical Biochemistry: Metabolic and Clinical Aspects
PB - Churchill Livingstone
ER -